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The use of anion-exchange chromatography was investigated as an alternative method to concentrate
and purify bacterial viruses, and parameters for different bacteriophages were compared. Chromato-
graphy was performed with Convective Interactive Medias monoliths, with three different volumes
and two matrix chemistries. Eleven morphologically distinct phages were tested, infecting ﬁve different
bacterial species. For each of the phages tested, a protocol was optimized, including the choice of
column chemistry, loading, buffer and elution conditions. The capacity and recovery of the phages on
the columns varied considerably between phages. We conclude that anion-exchange chromatography
with monoliths is a valid alternative to the more traditional CsCl puriﬁcation, has upscaling advantages,
but it requires more extensive optimization.
& 2012 Elsevier Inc. All rights reserved.Introduction
Many applications in bacteriophage research (e.g. genomics,
proteomics, electron microscopy and crystallography) require
pure and highly concentrated phage suspensions (Ackermann,
2009; Lavigne et al., 2009; Rossmann et al., 2005). Also for the use
in phage therapy, puriﬁcation steps are needed, depending on the
type of application, medical (topical or systemic), agricultural or
in veterinary applications (Gill and Hyman, 2010). Traditionally,
this has been achieved by polyethylene glycol precipitation and
subsequent CsCl gradient ultracentrifugation (Boulanger, 2009;
Yamamoto et al., 1970). In most cases this method gives a
relatively low yield but a high quality phage preparation, yet forll rights reserved.
ven.be (E.M. Adriaenssens),
eegen),
uvel),
e.gatech.edu (A.J. Garcı´a),some phages it does not work. Phages either get damaged by the
centrifugal forces, suffer from osmotic shock or interact with CsCl
and lose their infectivity (Carlson, 2005). Although the latter two
situations may be remedied by using another type of gradient
(e.g. sucrose gradient; Serwer et al., 1978), gradient separations in
general are cumbersome and do not easily permit upscaling of the
process.
The inability of some phages to be puriﬁed with CsCl gradients
is common knowledge in the lab, but little has been published on
speciﬁc phages exhibiting this behavior. The giant myovirus
phage 0305Ø8-36 infecting Bacillus thurengiensis shows a drop
in viable phages after CsCl ultracentrifugation because of con-
traction of the tail sheath (Pathria et al., 2012). Another giant
myovirus, B. megatherium phage G expells DNA from the capsid in
CsCl and is puriﬁed with rate zonal centrifugation in a sucrose
gradient (Serwer, personal communcation, Serwer et al., 2009).
Three phages used in this study, Dickeya phages LIMEstone1 and
LIMEstone2 and Pseudomonas phage Ø15, show a signiﬁcant drop
in titer after CsCl puriﬁcation, while the Pseudomonas phages
ØPaer4 and ØE2005-A aggregate and precipitate during CsCl
centrifugation.
An alternative method for the puriﬁcation of bacteriophages is
chromatography. In 1953, Puck and Sagik proved that phages T1
and T2 could bind to anionic (nalcite) or cationic (dowex) resins,
Table 1
Bacteriophages puriﬁed with CIMs monolithic columns.
Phage Phage family (morphotype) Host species Host strain
Growth
medium
Loading
suspensiona
Columns usedb
Optimized
Buffer
setc
Elution of pure
phage fraction
Capacity (pfu/ml
column)
Recovery
of phage
in pure
fraction
(%)
Reference
Dickeya phage
LIMEstone1
Myoviridae (ViI-like) ‘‘D. solani’’ GBBC 2072 LB Undiluted
CIMs QA/DEAE
disk
Tris(a) 0.6 M NaCl 47.41012 99.9 (Adriaenssens
et al., 2012)
Dickeya phage
LIMEstone2
Myoviridae (ViI-like) ‘‘D. solani’’ GBBC 2072 LB Diluted (1/2)
CIMs QA/DEAE
disk
phosphate 0.6 M NaCl 45.91011 70 (Adriaenssens
et al., 2012)
Staphylococcus
phage ISP
Myoviridae (Twort-like)
S. aureus subsp
aureus
Rosenbach
ATCC 6538
MH Undiluted
CIMs QA/DEAE
disk
Tris(a) 0.8 M NaCl 42.91011 35–65
(Merabishvili
et al., 2009;
Vandersteegen
et al., 2011)
Pseudomonas
phage UE2005-A
Myoviridae (PB1-like) P. aeruginosa EAMS2005-A 25% TSB Diluted (1/1) CIMs QA-8 f Tris(a) 0.25 M NaCl 1.31011 40–70 R. Donland
Pseudomonas
phage UPaer14
Myoviridae (PB1-like) P. aeruginosa Paer14 25% TSB Diluted (1/1) CIMs QA-8 f Tris(a) 0.25 M NaCl 1.31011 40–70 R. Donlan
Pseudomonas
phage UE2005-C
Myoviridae (PB1-like) P. aeruginosa EAMS2005-C 25% TSB Diluted (1/1) CIMs QA-8 f Tris(a) 0.25 M NaCl 1.31011 40–70 R. Donlan
Pseudomonas
phage UM4
Myoviridae (KPP10-like) P. aeruginosa M4 25% TSB Diluted (1/1) CIMs QA-8 f Tris(a) 0.56 M NaCl 1.31011 40–70 (Lindberg and
Latta, 1974)
Burkholderia
phage Phi208
Podoviridae B. thailandensis DW503 LB Dialyzed CIMs QA disk Tris(b) 0.3 M NaCl 5.0109 70 This study
Pseudomonas
phage U15
Podoviridae (T7-like) P. putida PpG1 LB Diluted (1/2)
CIMs QA/DEAE
disk
Tris(a) 0.3 M NaCl 2.41011 87
(Cornelissen
et al., 2011;
Shaburova et al.,
2009)
Pseudomonas
phage UPaer4
Podoviridae (LUZ24-like) P. aeruginosa Paer4 25% TSB Diluted (1/1)
CIMacTM QA;
CIMs QA-8 f
Tris(a) 0.3 M NaCl
Ac QA: 5109 to
11010
40–70 R. Donlan
QA-8f:
41.31011
Pseudomonas
phage LUZ19
Podoviridae (jKMV-like) P. aeruginosa PAO1 LB Diluted 1/2) CIM
s QA/DEAE
disk
Tris(a) 0.6 M NaCl 43.51012 70 (Ceyssens et al.,
2009)
a Undiluted: lysates were loaded; diluted: lysates were diluted in the corresponding loading buffer; dialyzed: phage suspension dialyzed against corresponding loading buffer.
b When multiple columns were tested, the best column for puriﬁcation is in bold.
c Tris(a) and Tris(b) buffers differ in composition as described in the materials and methods section.
d Rodney Donlan, CDC Bioﬁlm Lab, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
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E.M. Adriaenssens et al. / Virology 434 (2012) 265–270 267the latter only in the presence of salts, originally to study the
attachment of phages to the host cell. Anion-exchange chromato-
graphy of phages for puriﬁcation on ECTEOLA columns has been
described as early as 1957 (Creaser and Taussig, 1957; Taussig
and Creaser, 1957). For the lipid-containing phage PRD1, another
method was designed, using commercial Memsep cartridges with
quaternary methylamine and diethylaminoethyl (Walin et al.,
1994). More recently, Convective Interactive Medias (CIMs)
monoliths have become commercially available and have been
shown to effectively purify a number of phages, including
Escherichia phages T4, lambda and M13, and Staphylococcus phage
VDX-10 (Kramberger et al., 2010; Smrekar et al., 2008,2011). In
these reports, two types of anion-exchange matrices have been
examined, quaternary amine (QA) and diethyl amine (DEAE), the
latter only for VDX-10. As Kramberger et al. (2010) showed, the
same puriﬁcation conditions apply when scaling up, making
anion-exchange chromatography puriﬁcation ideal for large-
scale production of bacteriophage suspensions. Phage PRD1 was
also puriﬁed with 1 ml QA and DEAE CIMs monoliths which gave
a yield of up to 71013 pfu/column (Oksanen and Bamford, in
this issue).
In this paper, we describe the puriﬁcation of eleven morpho-
logically distinct phages which infect a range of bacterial hosts
using CIMs monolith anion-exchange chromatography. Columns
with two monolith types, and different volumes were tested.Results
Puriﬁcation of bacteriophages using CIMs monolithic columns
A set of phages (Table 1), with different morphologies and
which infect different hosts, was concentrated and puriﬁed on
CIMs monolithic columns. Dickeya phages LIMEstone1 and LIME-
stone2, Pseudomonas phages |15 and LUZ19, Staphylococcus phage
ISP and Burkholderia phage phi208 were tested on the laboratory
scale anion-exchange columns, the CIMs QA Disk Monolithic
Column (QA: strong anion exchanger) and/or the CIMs DEAE Disk
Monolithic Column (DEAE: weak anion exchanger). Pseudomonas
phage |Paer4 was tested on the CIMac
TM
QA-0.1 mL AnalyticalFig. 1. Linear gradient output diagramColumn and the industrial scale CIMs QA-8f mL Tube Monolithic
Column. The other Pseudomonas phages |E2005-A, |Paer14,
|E2005-C and |M4 were tested on the CIMs QA-8f mL Tube
Monolithic Column.
Optimizing the puriﬁcation of a phage with anion-exchange
chromatography is a stepwise process, in which different parameters
need to be taken into consideration, e.g. binding, elution, capacity of
the column and phage recovery.
Binding conditions
In the ﬁrst step, the speciﬁc binding conditions for each phage
were determined, using a one-step gradient loading and elution
approach. A small volume of phage suspension was loaded on a
column (usually 2 ml) and the ﬂow-through (FT) fraction was
collected as a whole. The particles were eluted in one step with
100% elution buffer and this fraction (E) was also collected. The
aim was to have no phage in the FT fraction. Various methods to
achieve binding can be used. (1) For phages ISP and LIMEstone1,
this was accomplished by simply loading ﬁltered (0.22 mm) lysate
onto the QA and DEAE disks. (2) The other phages had to be
diluted in their respective loading buffers (Table 1) to reduce ionic
strength and promote binding of the phage particles on the
column matrix or dilute lysate proteins which might bind to the
matrix. (3) In the case of phage phi208, the phage suspension was
dialyzed against the loading buffer. If only a small percentage of
phage is being recovered in the FT fraction, lowering the ﬂow
rates or total pfu being loaded may eliminate this loss.
Elution
In a next step, a linear elution gradient was used to calculate
the most optimal concentration of elution buffer, i.e. the NaCl
concentration of the buffer (Fig. 1, Table 1). Again, a small volume
of phage suspension was loaded on a column under conditions as
optimized in the ﬁrst step. The E fractions were divided among
the elution gradient and the corresponding phage titers were
determined. Using a loading system with UV or conductivity
detectors, peaks were visible when phages and/or impurities
were eluted. Combining this information with the titers of theof the puriﬁcation of phage ISP.
Fig. 2. Step gradient output diagram of the puriﬁcation of phage LIMEstone2 on a DEAE disk. Phage was eluted in fractions A4 and A5.
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for washing away impurities and for the actual elution of phage.
For the example of phage ISP in Fig. 1, phage elution started at
approximately 35% buffer B and therefore 40% buffer B was
chosen for phage elution. A higher elution concentration might
have had a higher yield of phage, but purity decreases as more
unwanted particles are co-eluted. NaCl elution concentrations
ranged between 0.25 M for phages |E2005-A and |Paer14, and
0.8 M for phage ISP; elution for the other phages was intermedi-
ate (Table 1). For complete elution of all particles after puriﬁca-
tion, 1 M of NaCl was sufﬁcient for phages LIMEstone1,
LIMEstone2, |15 and phi208; for |Paer4, |E2005-A, |E2005-C
and |Paer14 1.5 M NaCl was used; phages LUZ19 and ISP required
2 M NaCl.
Step gradient, capacity and recovery
Based on the data previously collected, a step-wise gradient
was designed for each phage, using different concentrations of the
elution buffer to wash away impurities, elution of phage and
removal of the remaining phage and impurities of the column
(example in Fig. 2). Depending on the delay of the FPLC system
(between the UV detector and the fractionator), the concentration
of elution buffer used, was somewhat lower than initially
expected from the linear gradient. This could be minimalized by
lengthening the linear gradient to better calculate the concentra-
tion of elution buffer for each step. From this step-wise gradient,
the capacity of the column could be determined by loading an
excess of phage and collecting the FT in different fractions.
Different phages gave different capacities on the same columns.
For example, the laboratory scale DEAE disk could bind per ml
over 51011 pfu of LIMEstone2 (6.21011 pfu added per column
volume, capacity not reached), but less than half as many
particles of |15, 2.41011 pfu/ml column (2.71011 pfu added,
capacity reached). Often, on a laboratory scale, the maximum
capacity of the columns was not reached as the limiting factor
was the phage ampliﬁcation step combined with the amount of
suspension that could be loaded on the system. In the case ofPseudomonas phage |Paer4, the analytical QA column had a
maximum capacity of 1109 pfu (11010 pfu/column volume),
which was deemed too low and the process was scaled up to the
industrial scale QA-8f tubes. Here, a yield of 11012 pfu was
achieved (1.31011 pfu/column volume), similar to that of
|E2005-A, |Paer14, |E2005-C and |M4. This 1000-fold higher
yield between the columns is only partly explained by their
difference in volume (per column volume, we have a 13 fold
increase) and we suspect that the matrix and column build are
also responsible (disk versus tube, respectively).
The recovery of phages in the pure elution fraction was also
calculated as the ratio of total phage found in the pure fractions to
the total number of phage loaded on the column (Table 1).
Generally, a considerable loss of phage was witnessed, from 30
to 65% of phages could be washed away in the FT fractions, in
other E fractions or were too strongly bound to the column
matrix. Only phage LIMEstone1 showed a recovery of 99.9%.Discussion
A number of observations can be made from comparing the
different bacteriophages and the different columns.
Considering the results for the different phages, it is clear that
the protocol needs to be optimized for each phage individually. The
protocol may be almost identical for similar phages, for example
Pseudomonas phages |E2005-A, |Paer14 and |M4, or the optimal
conditions might have other column chemistries and buffer condi-
tions, as for Dickeya phages LIMEstone1 and LIMEstone2.
For each phage, the appropriate column type and volume
needs to be chosen, depending on the required titer of the end
product. The laboratory scale columns of 0.34 ml used in this
study gave yields of 3 to 5 ml of 1011 to 1012 pfu/ml elution
fraction (LIMEstone1, LIMEstone2, LUZ19) which is sufﬁcient for
most small scale experiments. The analytical scale column
CIMac
TM
QA produced a lower titer than desirable for phage
|Paer4 (maximum capacity of 1109 pfu/column, while at least
1011 pfu/column is necessary to reach high concentrations in the
E.M. Adriaenssens et al. / Virology 434 (2012) 265–270 269elution fraction) and the process was successfully scaled up to the
industrial scale 8 ml CIMs QA-8f column with the same opti-
mized conditions. Consequently, it is always possible to ﬁrst
optimize the protocol on a laboratory scale or analytical scale
column, and then a larger volume industrial scale column can be
used for large-scale applications. The anion-exchange columns
can be used more than once, although, after multiple usages it
was noted that the capacity may sometimes be reduced. A new
CIMs DEAE laboratory scale column had a capacity of more than
1.21012 LUZ19 phage particles, whereas an older column, which
was used several times for different phages, could not retain more
than 9.71010 pfu. Perhaps some particles are bound too
strongly to the column matrix and cannot be eluted, even when
using a high molarity of NaCl solution. To keep the columns in
optimal condition, it is recommended to regenerate the counter-
ions before and after every use, according to manufacturer’s
instructions.
Loss of phage titer was almost always observed during the
puriﬁcation process, when comparing the total number of phage
loaded and eluted. This was also observed by Smrekar et al. (2008)
and Kramberger et al. (2010) with recoveries which ranged from 60
to 70%. In our study, recovery seems lower for some phages, but we
looked at the purest elution fraction alone, and disregarded phage
loss in the other fractions. It has proven possible to increase
capacity to 100% by drastically reducing the NaCl concentration at
loading (Smrekar et al. 2010). However, this necessitates either an
increase in the loaded volume of phage suspension (extra dilution)
or an extra step (dialysis) prior to phage loading. Dialysis, in
particular, may not be practical for large volumes, making the
slight loss of phage an acceptable trade-off for the increased speed
of puriﬁcation. Loss of phage can also consistently occur for CsCl-
gradient centrifugation puriﬁcation. This can happen at many
stages in the puriﬁcation process, before the centrifugation step
during PEG precipitation and/or resuspension, during centrifugation
because of interaction with CsCl or in the dialysis step after
centrifugation. Moreover, for phages |15, LIMEstone1 and LIME-
stone2 the latter resulted in dramatic phage losses of up to 5 orders
of magnitude. For these phages, the use of the monoliths is an
excellent alternative puriﬁcation method on a laboratory scale.
In principle, it should be possible to separate a mixture of two
phages with different elution conditions on the anion-exchange
columns. However, for a number of phages a small titer of
residual phage particles (103 to 105 pfu/ml FT fraction) was found
in most of the fractions of the binding process (LIMEstone1,
LIMEstone2, ISP, LUZ19 and |Paer4). Use of the columns for this
purpose holds therefore the risk of contamination. When reusing
columns with different phages, washing with 1 M NaOH proved
to remove all viable phage particles from the matrix and from the
FPLC system, as tested by spotting random pump wash samples
on an agar overlay with the appropriate bacterium.
A comparison between the anion-exchange chromatography
method using CIMs monoliths and traditional CsCl gradient
ultracentrifugation, factors in many parameters. When looking
at yield only, CsCl puriﬁcation can generally reach higher yields
per sample than the 0.34 ml and 8 ml columns used in this study.
However, because of the centrifugation step in the CsCl method,
the volume of phage suspension used in each sample is con-
stricted, while for the chromatography method an unlimited
volume of phages can be loaded on each column (with the
appropriate FPLC or HPLC pump and loading system). This offers
an extra advantage for phages which do not amplify well in the
previous step of liquid or plate ampliﬁcation. Also, the CIMs
monoliths’ scaleability under previously optimized conditions
would permit higher titers to be reached when using the larger
industrial-scale columns which were not investigated in this
study. The purity of the resulting phage suspensions was notstudied in detail, but preliminary SDS-PAGE analyses for LIME-
stone1 and |15 indicated that the purity of the two methods is
comparable. Supplementary Fig. 1 illustrates this for LIMEstone1.
After the optimization process, the chromatographic method is
faster than CsCl puriﬁcation. Layering of CsCl gradients is a time-
consuming process, followed by a centrifugation step that lasts
1 to 3 h, ﬁnishing with dialysis of the phage suspension which in
turn takes several hours. Starting from loading the phage suspen-
sion on a column, the whole chromatography process usually
does not take longer than an hour, depending on the volume
loaded and ﬂow rate used, and the resulting phage elution
suspension can be stored directly.
When looking at cost, both methods require expensive equip-
ment, an HPLC or FPLC for chromatography and an ultracentrifuge
for CsCl puriﬁcation. Obviously, HPLC/FPLC has broader general
applicability in terms of e.g. protein puriﬁcation. Apart from that,
the amount of CsCl needed to process one phage sample is
cheaper than one column, but the latter can be reused a number
of times, making it cheaper after several reuses.
In conclusion, the technique of anion-exchange chromatogra-
phy with CIMs monoliths offers a valid alternative for traditional
benchtop puriﬁcation methods, especially for phages which prove
to be unstable in these traditional methods. Additionally, the
columns are easily scalable without the need for further optimi-
zation. Drawbacks are a noticeable loss of phage during the
puriﬁcation process and a potentially long optimization process.
Therefore, the decision to use this method needs to be made for
each phage separately.Materials and methods
Phage ampliﬁcation
Dickeya phages LIMEstone1 and LIMEstone2, Pseudomonas
phages |15, LUZ19, |Paer4, |E2005-A, |Paer14, |E2005-C and |M4
and Staphylococcus phage ISP (see Table 1) were ampliﬁed in liquid
culture, the ﬁrst four in LB broth (10 g/l Tryptone, 5 g/l yeast
extract, 10 g/l NaCl), the following ﬁve in 25% TSB broth (Becton,
Dickinson and Company, Sparks, USA) and ISP in Mueller Hinton
(MH) broth (Becton, Dickinson and Company, Sparks, USA)
(Table 1). Phages were added to an exponential phase shaking
culture of their respective bacterial host at 106–107 cfu/ml and
incubated at 37 1C (non-Dickeya phages) or 28 1C (Dickeya phages)
until lysis occurred (culture visibly cleared). The resulting lysate
was clariﬁed further by adding 0.5 to 2% (v/v) of chloroform,
decanting, centrifugation and ﬁltration of the supernatant (0.2 mm
pore size). Burkholderia phage phi208 was ampliﬁed by conﬂuent
lysis on LB agar plates at 37 1C.Concentration using CIMs monoliths
Three different buffer systems were used for loading the
phages on the columns: Tris(a) buffer (20 mM Tris–HCl, pH 7.5),
Tris(b) buffer (50 mM Tris–HCl, pH 7.5, 8 mM MgSO4) or phos-
phate buffer (125 mM Na2HPO4, pH 7.2). For elution, 1 to 2 M
NaCl was added to the loading buffer, depending on the phage.
The anion-exchange chromatography columns used were the
laboratory scale CIMs QA and DEAE disks (0.34 ml), the analytical
CIMacTM QA column (0.1 ml) and the industrial scale CIMs QA-8f
mL Tube Column (8 ml) (BIA Separations, Ljubljana, Slovenia). The
columns were attached to an A¨KTA
TM
FPLC
TM
system (GE Health-
care, Little Chalfont, UK) with a P900 pump system and analyzed
with UNICORN
TM
5.01 software.
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Phages were enumerated with plaque assays using the tradi-
tional agar-overlay method (Adams, 1959).Acknowledgments
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